CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: organochlorine acaricide
Accession: CHEBI:38657
browse the term
Definition: Any organochlorine pesticide that has been used as an acaricide.
Synonyms: related_synonym: chlororganische Akarizide; organochloride acaricide; organochloride acaricides; organochlorine acaricides
G
Ache
acetylcholinesterase
decreases activity
ISO EXP
azamethiphos results in decreased activity of ACHE protein
CTD
PMID:21251949 PMID:33844597
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
EXP
azamethiphos promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA]
CTD
PMID:28385489
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
multiple interactions
EXP
azamethiphos promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA]
CTD
PMID:28385489
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Gap43
growth associated protein 43
multiple interactions
EXP
azamethiphos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA]
CTD
PMID:28385489
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Ngf
nerve growth factor
multiple interactions
EXP
azamethiphos promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA]; azamethiphos promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA]; azamethiphos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA]
CTD
PMID:28385489
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ache
acetylcholinesterase
multiple interactions decreases activity
ISO EXP
asoxime chloride inhibits the reaction [Chlorfenvinphos results in decreased activity of ACHE protein]; HLo 7 inhibits the reaction [Chlorfenvinphos results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Chlorfenvinphos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Chlorfenvinphos results in decreased activity of ACHE protein]
CTD
PMID:1855619 PMID:2340983 PMID:6933967 PMID:8783813 PMID:16201202 PMID:33844597 More...
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased expression of CYP3A4 mRNA
CTD
PMID:25028461
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased activity of NR1I2 protein
CTD
PMID:25028461
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Tp53
tumor protein p53
affects activity
ISO
Chlorfenvinphos metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ar
androgen receptor
multiple interactions
ISO
Dihydrotestosterone inhibits the reaction [chloropropylate results in increased activity of AR protein]
CTD
PMID:15064155
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Esr1
estrogen receptor 1
increases activity
ISO
chloropropylate results in increased activity of ESR1 protein
CTD
PMID:15064155
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases activity
ISO
chloropropylate results in increased activity of ESR2 protein
CTD
PMID:15064155
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
chloropropylate binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Ache
acetylcholinesterase
decreases activity decreases expression multiple interactions decreases response to substance increases phosphorylation increases acylation
ISO EXP
Dichlorvos metabolite results in decreased activity of ACHE protein; Dichlorvos results in decreased activity of ACHE protein Dichlorvos results in decreased expression of ACHE mRNA; Dichlorvos results in decreased expression of ACHE protein 1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; [Dichlorvos co-treated with Monocrotophos] results in increased activity of ACHE protein; [Monocrotophos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [pralidoxime co-treated with Atropine] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; [sodium arsenite co-treated with Dichlorvos co-treated with Monocrotophos] results in decreased activity of ACHE protein; [sodium arsenite co-treated with Dichlorvos] results in decreased activity of ACHE protein; Dichlorvos inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [[Atropine co-treated with Curcumin] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein] ACHE protein results in decreased susceptibility to Dichlorvos Dichlorvos results in increased phosphorylation of ACHE protein Dichlorvos results in increased acylation of ACHE protein [bacoside A co-treated with Plant Preparations] inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; Atropine promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; coumarin inhibits the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; Dichlorvos binds to and results in decreased activity of ACHE protein; Dichlorvos promotes the reaction [malaoxon results in decreased activity of ACHE protein]; Gallamine Triethiodide affects the reaction [Dichlorvos results in increased acylation of ACHE protein]; Gallamine Triethiodide promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; Propidium promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Tubocurarine promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein] [Carbaryl co-treated with Dichlorvos] results in decreased activity of ACHE protein; [crotoxyphos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Dichlorvos results in increased phosphorylation of ACHE protein] inhibits the reaction [thioflavin T binds to ACHE protein]; [malaoxon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Malathion co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Mevinphos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Paraoxon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Parathion co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Phosphamidon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Physostigmine co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Trichlorfon co-treated with Dichlorvos] results in decreased activity of ACHE protein; asoxime chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Dichlorvos promotes the reaction [Chlorpromazine results in decreased activity of ACHE protein]; HLo 7 inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Tiapamil Hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]
CTD
PMID:119426 PMID:235931 PMID:473212 PMID:475593 PMID:597376 PMID:1258061 PMID:1494302 PMID:1609424 PMID:1855619 PMID:2086312 PMID:2537085 PMID:3247000 PMID:3945941 PMID:4859365 PMID:6933967 PMID:7150809 PMID:7218377 PMID:7234437 PMID:7713347 PMID:8231460 PMID:8359835 PMID:8579882 PMID:8783813 PMID:9268605 PMID:9515941 PMID:9586870 PMID:10421444 PMID:10975133 PMID:12018594 PMID:14631503 PMID:15033007 PMID:15679473 PMID:15793557 PMID:15979224 PMID:16036766 PMID:16193528 PMID:16598855 PMID:16978018 PMID:17188317 PMID:17722737 PMID:18070496 PMID:18423506 PMID:19100812 PMID:19631781 PMID:20026515 PMID:20396698 PMID:20412842 PMID:21251949 PMID:21349312 PMID:21673941 PMID:21767560 PMID:22209767 PMID:22783142 PMID:23220589 PMID:25082528 PMID:25895260 PMID:26814074 PMID:27899289 PMID:30625376 PMID:33517499 PMID:33574433 PMID:33720374 PMID:33844597 PMID:34078836 More...
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
affects localization multiple interactions
EXP
Dichlorvos affects the localization of AIFM1 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos affects the localization of AIFM1 protein]
CTD
PMID:24231740
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akr7a3
aldo-keto reductase family 7 member A3
increases expression
EXP
Dichlorvos results in increased expression of AKR7A3 mRNA
CTD
PMID:21813463
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Alb
albumin
affects binding
ISO
Dichlorvos binds to ALB protein
CTD
PMID:15525694 PMID:17188226
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
Dichlorvos results in increased expression of ALDH1A1 mRNA
CTD
PMID:21813463
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Anxa2
annexin A2
increases expression
EXP
Dichlorvos results in increased expression of ANXA2 mRNA
CTD
PMID:21813463
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Apeh
acylaminoacyl-peptide hydrolase
decreases activity
ISO EXP
Dichlorvos results in decreased activity of APEH protein
CTD
PMID:15888665 PMID:19379766
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
G
App
amyloid beta precursor protein
increases secretion
ISO EXP
Dichlorvos results in increased secretion of APP protein alternative form Dichlorvos results in increased secretion of APP protein modified form
CTD
PMID:7605915 PMID:8624119 PMID:11526466
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Ar
androgen receptor
multiple interactions
ISO
Dichlorvos promotes the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:17219378
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atm
ATM serine/threonine kinase
multiple interactions increases expression
EXP
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of ATM mRNA] Dichlorvos results in increased expression of ATM mRNA; Dichlorvos results in increased expression of ATM protein
CTD
PMID:24369695
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Dichlorvos results in increased expression of BAX protein
CTD
PMID:22817663
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bche
butyrylcholinesterase
multiple interactions decreases expression decreases activity
ISO EXP
[Dichlorvos results in decreased activity of BCHE protein] which results in increased susceptibility to Succinylcholine; Dichlorvos binds to and results in decreased activity of BCHE protein; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; Tiapamil Hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein] Dichlorvos results in decreased expression of BCHE protein diacetylmonoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; Magnesium Sulfate promotes the reaction [Dichlorvos results in decreased activity of BCHE protein] [bacoside A co-treated with Plant Preparations] inhibits the reaction [Dichlorvos results in decreased expression of BCHE protein]; Dichlorvos binds to and results in decreased activity of BCHE protein
CTD
PMID:235931 PMID:423703 PMID:1276991 PMID:4631366 PMID:7150809 PMID:12190811 PMID:12828128 PMID:16036766 PMID:16193528 PMID:16598855 PMID:17698511 PMID:19504058 PMID:20229498 PMID:20395308 PMID:21673941 PMID:21767560 PMID:22209767 PMID:27899289 PMID:33517499 More...
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
Dichlorvos results in increased expression of BTG2 mRNA
CTD
PMID:21813463
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Casp1
caspase 1
increases expression
EXP
Dichlorvos results in increased expression of CASP1 mRNA
CTD
PMID:23053939
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases activity increases cleavage increases expression decreases expression multiple interactions
ISO EXP
Dichlorvos results in increased activity of CASP3 protein Dichlorvos results in increased cleavage of CASP3 protein Dichlorvos results in increased expression of CASP3 mRNA Dichlorvos results in decreased expression of CASP3 mRNA [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; Dichlorvos results in increased cleavage of and results in increased activity of CASP3 protein; mitoquinone inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased cleavage of CASP3 protein] benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]
CTD
PMID:16973328 PMID:17681413 PMID:17850875 PMID:19815060 PMID:21784090 PMID:22817663 PMID:24369695 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions increases activity
EXP
[Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]
CTD
PMID:16973328
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases activity decreases activity
EXP ISO
[Hexachlorocyclohexane co-treated with Dichlorvos co-treated with Plant Extracts] results in decreased activity of CAT protein; [Hexachlorocyclohexane co-treated with Dichlorvos] results in decreased activity of CAT protein; [Phorate co-treated with acephate co-treated with Dichlorvos co-treated with Dimethoate] results in decreased activity of CAT protein; Acetylcysteine inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; coenzyme Q10 inhibits the reaction [Dichlorvos results in decreased activity of CAT protein] Dichlorvos results in increased activity of CAT protein PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]
CTD
PMID:1587340 PMID:20302853 PMID:22034174 PMID:22224058 PMID:22751200 PMID:25891459 PMID:26814074 PMID:27180203 PMID:29143438 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cdc25a
cell division cycle 25A
increases expression multiple interactions
EXP
Dichlorvos results in increased expression of CDC25A mRNA; Dichlorvos results in increased expression of CDC25A protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDC25A mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDC25A protein]
CTD
PMID:24369695
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
EXP
Dichlorvos results in increased expression of CDKN1A mRNA; Dichlorvos results in increased expression of CDKN1A protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDKN1A mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDKN1A protein]
CTD
PMID:21813463 PMID:24369695
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Ces2h
carboxylesterase 2H
increases expression
EXP
Dichlorvos results in increased expression of CES2 mRNA
CTD
PMID:21813463
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Chat
choline O-acetyltransferase
increases activity
EXP
Dichlorvos results in increased activity of CHAT protein
CTD
PMID:17722737
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
G
Chek2
checkpoint kinase 2
multiple interactions increases expression
EXP
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CHEK2 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CHEK2 protein] Dichlorvos results in increased expression of CHEK2 mRNA; Dichlorvos results in increased expression of CHEK2 protein
CTD
PMID:24369695
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Chrm1
cholinergic receptor, muscarinic 1
decreases expression
EXP
Dichlorvos results in decreased expression of CHRM1 protein
CTD
PMID:19100812
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Chrm2
cholinergic receptor, muscarinic 2
decreases expression
EXP
Dichlorvos results in decreased expression of CHRM2 protein
CTD
PMID:19100812
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chrm3
cholinergic receptor, muscarinic 3
decreases expression
EXP
Dichlorvos results in decreased expression of CHRM3 protein
CTD
PMID:19100812
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
ISO
Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]
CTD
PMID:15733544
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]
CTD
PMID:15733544
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Cnr1
cannabinoid receptor 1
multiple interactions decreases activity
ISO
Dichlorvos inhibits the reaction [CP 55244 binds to CNR1 protein] Dichlorvos results in decreased activity of CNR1 protein
CTD
PMID:12243867
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation
EXP
Dichlorvos results in decreased phosphorylation of CREB1 protein
CTD
PMID:19100812
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Cybb
cytochrome b-245 beta chain
increases expression
EXP
Dichlorvos results in increased expression of CYBB mRNA; Dichlorvos results in increased expression of CYBB protein
CTD
PMID:21964614
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
EXP
Dichlorvos affects the localization of CYCS protein mitoquinone inhibits the reaction [Dichlorvos affects the localization of CYCS protein]
CTD
PMID:17850875 PMID:21784090
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Dbh
dopamine beta-hydroxylase
increases activity multiple interactions
EXP
Dichlorvos results in increased activity of DBH protein Nimodipine inhibits the reaction [Dichlorvos results in increased activity of DBH protein]
CTD
PMID:12186780
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Dlg2
discs large MAGUK scaffold protein 2
affects response to substance
ISO
DLG2 gene SNP affects the susceptibility to Dichlorvos
CTD
PMID:25622337
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
G
Drd2
dopamine receptor D2
decreases activity multiple interactions
EXP
Dichlorvos results in decreased activity of DRD2 protein Nimodipine inhibits the reaction [Dichlorvos results in decreased activity of DRD2 protein]
CTD
PMID:12186780
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Esr1
estrogen receptor 1
decreases activity
ISO
Dichlorvos results in decreased activity of ESR1 protein
CTD
PMID:22562034
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fas
Fas cell surface death receptor
decreases expression
ISO
Dichlorvos results in decreased expression of FAS protein
CTD
PMID:15369847
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
decreases expression
ISO
Dichlorvos results in decreased expression of FASL protein
CTD
PMID:15369847
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gabrd
gamma-aminobutyric acid type A receptor subunit delta
decreases expression
EXP
Dichlorvos results in decreased expression of GABRD mRNA
CTD
PMID:19146868
NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:165,958,484...165,970,411
G
Gck
glucokinase
decreases activity increases expression
EXP
Dichlorvos results in decreased activity of GCK protein Dichlorvos results in increased expression of GCK mRNA
CTD
PMID:16153661
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gsr
glutathione-disulfide reductase
decreases expression increases activity decreases activity multiple interactions
EXP
Dichlorvos results in decreased expression of GSR protein Dichlorvos results in increased activity of GSR protein Dichlorvos results in decreased activity of GSR protein [Hexachlorocyclohexane co-treated with Dichlorvos co-treated with Plant Extracts] results in decreased activity of GSR protein; [Hexachlorocyclohexane co-treated with Dichlorvos] results in decreased activity of GSR protein; Dichlorvos inhibits the reaction [sodium arsenite results in increased activity of GSR protein]; Plant Extracts inhibits the reaction [Dichlorvos results in decreased activity of GSR protein]; sodium arsenite inhibits the reaction [Dichlorvos results in increased activity of GSR protein]
CTD
PMID:18539328 PMID:20302853 PMID:22224058 PMID:22751200 PMID:25895260
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gys2
glycogen synthase 2
increases activity
EXP
Dichlorvos results in increased activity of GYS2 protein
CTD
PMID:222008
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
G
Gzma
granzyme A
decreases expression
ISO
Dichlorvos results in decreased expression of GZMA mRNA; Dichlorvos results in decreased expression of GZMA protein
CTD
PMID:16002202
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
G
Gzmb
granzyme B
decreases expression
ISO
Dichlorvos results in decreased expression of GZMB protein
CTD
PMID:18063463
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Gzmk
granzyme K
decreases expression
ISO
Dichlorvos results in decreased expression of GZMK protein
CTD
PMID:18063463
NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894
G
Hdc
histidine decarboxylase
increases activity
EXP
Dichlorvos results in increased activity of HDC protein
CTD
PMID:119426
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hk1
hexokinase 1
decreases activity
EXP
Dichlorvos results in decreased activity of HK1 protein
CTD
PMID:10544956
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hmox1
heme oxygenase 1
decreases expression multiple interactions
ISO
Dichlorvos results in decreased expression of HMOX1 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of HMOX1 protein]
CTD
PMID:26814074
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Ifng
interferon gamma
decreases expression multiple interactions
EXP
Dichlorvos results in decreased expression of IFNG protein [Dichlorvos co-treated with cyfluthrin co-treated with Xylenes co-treated with Kerosene] affects the expression of IFNG protein
CTD
PMID:12838427 PMID:19145326
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
increases expression increases secretion
EXP
Dichlorvos results in increased expression of IL1B mRNA; Dichlorvos results in increased expression of IL1B protein Dichlorvos results in increased secretion of IL1B protein
CTD
PMID:21964614 PMID:22817663
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
decreases response to substance
ISO
Dichlorvos results in decreased susceptibility to IL2 protein
CTD
PMID:8349949
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
increases expression
EXP
Dichlorvos results in increased expression of IL6 mRNA; Dichlorvos results in increased expression of IL6 protein
CTD
PMID:21964614
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
EXP
INS1 protein inhibits the reaction [Dichlorvos results in increased abundance of Glucose]
CTD
PMID:222008
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Itgam
integrin subunit alpha M
increases expression multiple interactions
EXP
Dichlorvos results in increased expression of ITGAM mRNA; Dichlorvos results in increased expression of ITGAM protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of ITGAM protein]
CTD
PMID:21964614 PMID:22817663 PMID:24369695
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Lcat
lecithin cholesterol acyltransferase
decreases activity multiple interactions
ISO
Dichlorvos results in decreased activity of LCAT protein Dichlorvos inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters]
CTD
PMID:4847537
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lpl
lipoprotein lipase
decreases activity
EXP
Dichlorvos results in decreased activity of LPL protein
CTD
PMID:3196159
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Maoa
monoamine oxidase A
decreases activity
EXP
Dichlorvos results in decreased activity of MAOA protein
CTD
PMID:12018584
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Maob
monoamine oxidase B
decreases activity
EXP
Dichlorvos results in decreased activity of MAOB protein
CTD
PMID:12018584
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map2
microtubule-associated protein 2
multiple interactions increases phosphorylation
EXP
Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein]
CTD
PMID:11282359 PMID:16635102
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
EXP
Dichlorvos results in increased expression of MGMT mRNA
CTD
PMID:21813463
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Nceh1
neutral cholesterol ester hydrolase 1
affects expression decreases activity
EXP ISO
Dichlorvos affects the expression of NCEH1 protein modified form Dichlorvos results in decreased activity of NCEH1 protein
CTD
PMID:6245657 PMID:16978018
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
G
Nefh
neurofilament heavy chain
affects expression
EXP
Dichlorvos affects the expression of NEFH mRNA
CTD
PMID:22954530
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
decreases expression
EXP
Dichlorvos results in decreased expression of NEFL mRNA
CTD
PMID:19146868
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases activity decreases expression multiple interactions
ISO
Dichlorvos results in increased activity of NFE2L2 protein Dichlorvos results in decreased expression of NFE2L2 mRNA; Dichlorvos results in decreased expression of NFE2L2 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein]
CTD
PMID:20143881 PMID:25891459 PMID:26814074
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
increases expression multiple interactions
EXP
Dichlorvos results in increased expression of NOS2 mRNA; Dichlorvos results in increased expression of NOS2 protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of NOS2 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of NOS2 protein]
CTD
PMID:22817663 PMID:24369695
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases expression multiple interactions
ISO
Dichlorvos results in decreased expression of NQO1 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NQO1 protein]
CTD
PMID:26814074
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
increases activity increases cleavage multiple interactions
EXP
Dichlorvos results in increased activity of PARP1 protein Dichlorvos results in increased cleavage of PARP1 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos results in increased activity of PARP1 protein]
CTD
PMID:24231740
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases activity
ISO EXP
Dichlorvos results in decreased activity of PNPLA6 protein
CTD
PMID:7713347 PMID:9268605 PMID:9586870 PMID:10776595 PMID:11282359 PMID:11705460 More...
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Pomc
proopiomelanocortin
multiple interactions increases secretion
EXP
Dichlorvos inhibits the reaction [POMC protein modified form results in increased chemical synthesis of Adrenal Cortex Hormones] Dichlorvos results in increased secretion of POMC protein modified form
CTD
PMID:2993719 PMID:6245657
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pon1
paraoxonase 1
multiple interactions decreases activity decreases expression decreases response to substance
EXP ISO
1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)but-2-ene inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; asoxime chloride inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein] Dichlorvos results in decreased expression of PON1 mRNA; Dichlorvos results in decreased expression of PON1 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of HMOX1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NQO1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of PON1 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of PON1 protein] PON1 protein results in decreased susceptibility to Dichlorvos
CTD
PMID:20412842 PMID:25891459 PMID:26814074 PMID:29098328
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Prf1
perforin 1
decreases expression
ISO
Dichlorvos results in decreased expression of PRF1 mRNA; Dichlorvos results in decreased expression of PRF1 protein
CTD
PMID:16002202
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
multiple interactions increases expression
EXP
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of PRKDC mRNA] Dichlorvos results in increased expression of PRKDC mRNA; Dichlorvos results in increased expression of PRKDC protein
CTD
PMID:24369695
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Pygb
glycogen phosphorylase B
increases activity
EXP
Dichlorvos results in increased activity of PYGB protein
CTD
PMID:10544956
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
G
Pygl
glycogen phosphorylase L
increases activity
EXP
Dichlorvos results in increased activity of PYGL protein
CTD
PMID:222008
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Scarb2
scavenger receptor class B, member 2
multiple interactions
EXP
[Dichlorvos co-treated with Methylnitrosourea] results in increased expression of SCARB2 protein
CTD
PMID:37469457
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Scgb1a1
secretoglobin family 1A member 1
multiple interactions
EXP
[Dichlorvos co-treated with cyfluthrin co-treated with Xylenes co-treated with Kerosene] results in increased expression of SCGB1A1 protein
CTD
PMID:12838427
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Snca
synuclein alpha
multiple interactions affects localization
EXP
coenzyme Q10 inhibits the reaction [Dichlorvos promotes the reaction [SNCA protein binds to SNCA protein]]; Dichlorvos promotes the reaction [SNCA protein binds to SNCA protein] Dichlorvos affects the localization of SNCA protein
CTD
PMID:21073741 PMID:21843543
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sod2
superoxide dismutase 2
multiple interactions decreases activity
EXP
[mitoquinone results in increased expression of SOD2 protein] which results in decreased susceptibility to Dichlorvos; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of SOD2 protein]
CTD
PMID:17850875 PMID:21784090 PMID:24231740
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
EXP
Dichlorvos results in increased expression of TAP1 mRNA
CTD
PMID:21813463
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tat
tyrosine aminotransferase
multiple interactions increases expression
EXP
[Atropine co-treated with Obidoxime Chloride co-treated with Diazepam] inhibits the reaction [Dichlorvos results in increased expression of TAT protein]
CTD
PMID:7761789
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tf
transferrin
affects binding
ISO
Dichlorvos binds to TF protein Dichlorvos binds to TRF protein
CTD
PMID:18930948
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Th
tyrosine hydroxylase
increases activity multiple interactions
EXP
Dichlorvos results in increased activity of TH protein Nimodipine inhibits the reaction [Dichlorvos results in increased activity of TH protein]
CTD
PMID:12186780
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
increases expression increases secretion
EXP
Dichlorvos results in increased expression of TNF mRNA; Dichlorvos results in increased expression of TNF protein Dichlorvos results in increased secretion of TNF protein
CTD
PMID:21964614 PMID:22817663 PMID:23053939
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
decreases expression increases expression multiple interactions
EXP
Dichlorvos results in decreased expression of TP53 mRNA Dichlorvos results in increased expression of TP53 mRNA; Dichlorvos results in increased expression of TP53 protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 protein]
CTD
PMID:23053939 PMID:24369695
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tubb5
tubulin, beta 5 class I
increases phosphorylation
EXP
Dichlorvos results in increased phosphorylation of TUBB protein
CTD
PMID:11282359 PMID:16635102
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Ugp2
UDP-glucose pyrophosphorylase 2
decreases activity
EXP
Dichlorvos results in decreased activity of UGP2 protein
CTD
PMID:222008
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Xab2
XPA binding protein 2
affects response to substance
ISO
XAB2 gene SNP affects the susceptibility to Dichlorvos
CTD
PMID:22102698
NCBI chr12:1,667,672...1,679,702
Ensembl chr12:1,667,672...1,679,692
G
Alb
albumin
multiple interactions
ISO
Dicofol binds to and affects the folding of ALB protein
CTD
PMID:34656558
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ar
androgen receptor
affects binding multiple interactions
ISO
Dicofol binds to AR protein Dicofol inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Dicofol inhibits the reaction [Metribolone results in increased activity of AR protein]; Dihydrotestosterone inhibits the reaction [Dicofol results in increased activity of AR protein]
CTD
PMID:15064155 PMID:15253041 PMID:18324785 PMID:21310686
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
Dicofol results in decreased activity of CYP19A1 protein
CTD
PMID:10806373
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Dicofol results in increased expression of CYP1A1 mRNA; Dicofol results in increased expression of CYP1A1 protein
CTD
PMID:19595748
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
Dicofol results in increased expression of CYP1A2 mRNA
CTD
PMID:19595748
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
Dicofol results in increased expression of CYP2B1 protein
CTD
PMID:19595748
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
Dicofol results in increased expression of CYP2B2 protein
CTD
PMID:19595748
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
EXP
Dicofol results in increased expression of CYP2E1 protein
CTD
PMID:19595748
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Dicofol results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:19595748
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Dio1
iodothyronine deiodinase 1
decreases activity
ISO
Dicofol results in decreased activity of DIO1 protein
CTD
PMID:29228274
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Esr1
estrogen receptor 1
affects binding multiple interactions increases activity
ISO
Dicofol binds to ESR1 protein Dicofol binds to and results in increased activity of ESR1 protein Dicofol results in increased activity of ESR1 protein
CTD
PMID:10789375 PMID:15064155 PMID:15253041 PMID:16337670 PMID:29162470
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases activity
ISO
Dicofol results in increased activity of ESR2 protein
CTD
PMID:15064155
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Ggt1
gamma-glutamyltransferase 1
increases activity
EXP
Dicofol results in increased activity of GGT1 protein
CTD
PMID:2387028
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gpt
glutamic--pyruvic transaminase
increases activity
EXP
Dicofol results in increased activity of GPT protein
CTD
PMID:2387028
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Ifnb1
interferon beta 1
multiple interactions
ISO
Dicofol inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]
CTD
PMID:18177342
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Dicofol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
Dicofol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein]
CTD
PMID:17015962
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
Dicofol binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
Dicofol results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Prkcb
protein kinase C, beta
multiple interactions increases activity
ISO
Calcium inhibits the reaction [Dicofol results in increased activity of PRKCB protein]; Phosphatidylserines promotes the reaction [Dicofol results in increased activity of PRKCB protein]
CTD
PMID:1724372
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Ttr
transthyretin
affects binding
EXP
Dicofol binds to TTR protein
CTD
PMID:2043046
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
flumethrin results in increased expression of BAX mRNA
CTD
PMID:34142587
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
flumethrin results in decreased expression of BCL2 mRNA
CTD
PMID:34142587
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
flumethrin results in increased expression of CDKN1A mRNA
CTD
PMID:34142587
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Esr1
estrogen receptor 1
increases expression
ISO
flumethrin results in increased expression of ESR1 mRNA
CTD
PMID:34142587
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases expression
ISO
flumethrin results in increased expression of ESR2 mRNA
CTD
PMID:34142587
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Pgr
progesterone receptor
increases expression
ISO
flumethrin results in increased expression of PGR mRNA
CTD
PMID:34142587
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Tff1
trefoil factor 1
increases expression
ISO
flumethrin results in increased expression of TFF1 mRNA
CTD
PMID:34142587
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tp53
tumor protein p53
increases expression
ISO
flumethrin results in increased expression of TP53 mRNA
CTD
PMID:34142587
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
fluvalinate analog promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:25684042
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Cdk2
cyclin dependent kinase 2
affects binding
ISO
fluvalinate binds to CDK2 protein
CTD
PMID:32278787
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects binding
ISO
fluvalinate binds to CYP3A4 protein
CTD
PMID:32278787
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Erbb2
erb-b2 receptor tyrosine kinase 2
affects binding
ISO
fluvalinate binds to ERBB2 protein
CTD
PMID:32278787
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Fgfr2
fibroblast growth factor receptor 2
affects binding
ISO
fluvalinate binds to FGFR2 protein
CTD
PMID:32278787
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Mmp9
matrix metallopeptidase 9
affects binding
ISO
fluvalinate binds to MMP9 protein
CTD
PMID:32278787
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nqo1
NAD(P)H quinone dehydrogenase 1
affects binding
ISO
fluvalinate binds to NQO1 protein
CTD
PMID:32278787
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
fluvalinate inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
fluvalinate binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Ppard
peroxisome proliferator-activated receptor delta
affects binding
ISO
fluvalinate binds to PPARD protein
CTD
PMID:32278787
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Rora
RAR-related orphan receptor A
affects binding
ISO
fluvalinate binds to RORA protein
CTD
PMID:32278787
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rorc
RAR-related orphan receptor C
affects binding
ISO
fluvalinate binds to RORC protein
CTD
PMID:32278787
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Aco2
aconitase 2
decreases activity
EXP
pyridaben results in decreased activity of ACO2 protein
CTD
PMID:26141520
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
G
Adam22
ADAM metallopeptidase domain 22
increases expression
ISO
pyridaben results in increased expression of ADAM22 mRNA
CTD
PMID:22563483
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
G
Adcyap1
adenylate cyclase activating polypeptide 1
increases expression
ISO
pyridaben results in increased expression of ADCYAP1 mRNA
CTD
PMID:22563483
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
G
Ago3
argonaute RISC catalytic component 3
increases expression
ISO
pyridaben results in increased expression of AGO3 mRNA
CTD
PMID:22563483
NCBI chr 5:138,632,367...138,714,230
Ensembl chr 5:138,639,569...138,714,230
G
Amn
amnion associated transmembrane protein
decreases expression
ISO
pyridaben results in decreased expression of AMN mRNA
CTD
PMID:22563483
NCBI chr 6:130,311,372...130,318,815
Ensembl chr 6:130,311,372...130,318,815
G
Ar
androgen receptor
multiple interactions
ISO
pyridaben inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:30818834
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atoh7
atonal bHLH transcription factor 7
decreases expression
ISO
pyridaben results in decreased expression of ATOH7 mRNA
CTD
PMID:22563483
NCBI chr20:25,530,826...25,531,275
Ensembl chr20:25,530,826...25,531,275
G
Atp8a2
ATPase phospholipid transporting 8A2
increases expression
ISO
pyridaben results in increased expression of ATP8A2 mRNA
CTD
PMID:22563483
NCBI chr15:33,817,309...34,350,193
Ensembl chr15:33,819,755...34,350,223
G
Bcl2
BCL2, apoptosis regulator
decreases response to substance multiple interactions
ISO
BCL2 protein results in decreased susceptibility to pyridaben PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben]
CTD
PMID:12730627
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
increases expression
ISO
pyridaben results in increased expression of BCL2A1 mRNA
CTD
PMID:22563483
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bicd1
BICD cargo adaptor 1
increases expression
ISO
pyridaben results in increased expression of BICD1 mRNA
CTD
PMID:22563483
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
G
C2cd4d
C2 calcium-dependent domain containing 4D
decreases expression
ISO
pyridaben results in decreased expression of C2CD4D mRNA
CTD
PMID:22563483
NCBI chr 2:181,999,778...182,001,941
Ensembl chr 2:181,997,078...182,002,087
G
Cabyr
calcium binding tyrosine phosphorylation regulated
increases expression
ISO
pyridaben results in increased expression of CABYR mRNA
CTD
PMID:22563483
NCBI chr18:3,892,062...3,904,391
Ensembl chr18:3,892,132...3,903,840
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
increases expression
ISO
pyridaben results in increased expression of CACNA1E mRNA
CTD
PMID:22563483
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
G
Camp
cathelicidin antimicrobial peptide
increases expression
ISO
pyridaben results in increased expression of CAMP mRNA
CTD
PMID:22563483
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
G
Capn11
calpain 11
decreases expression
ISO
pyridaben results in decreased expression of CAPN11 mRNA
CTD
PMID:22563483
NCBI chr 9:15,344,059...15,365,604
Ensembl chr 9:15,344,089...15,365,601
G
Casp3
caspase 3
increases expression
EXP
pyridaben results in increased expression of CASP3 mRNA; pyridaben results in increased expression of CASP3 protein
CTD
PMID:37357870
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccdc88a
coiled coil domain containing 88A
increases expression
ISO
pyridaben results in increased expression of CCDC88A mRNA
CTD
PMID:22563483
NCBI chr14:103,104,091...103,256,112
Ensembl chr14:103,103,513...103,252,368
G
Ccl19
C-C motif chemokine ligand 19
increases expression
ISO
pyridaben results in increased expression of CCL19 mRNA
CTD
PMID:22563483
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl21
C-C motif chemokine ligand 21
increases expression
ISO
pyridaben results in increased expression of CCL21A mRNA
CTD
PMID:22563483
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
G
Cdhr4
cadherin-related family member 4
decreases expression
ISO
pyridaben results in decreased expression of CDHR4 mRNA
CTD
PMID:22563483
NCBI chr 8:108,682,594...108,690,358
Ensembl chr 8:108,682,613...108,690,367
G
Cebpd
CCAAT/enhancer binding protein delta
decreases expression
ISO
pyridaben results in decreased expression of CEBPD mRNA
CTD
PMID:22563483
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
G
Cep290
centrosomal protein 290
increases expression
ISO
pyridaben results in increased expression of CEP290 mRNA
CTD
PMID:22563483
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
G
Cldn3
claudin 3
decreases expression
ISO
pyridaben results in decreased expression of CLDN3 mRNA
CTD
PMID:22563483
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Crlf2
cytokine receptor-like factor 2
decreases expression
ISO
pyridaben results in decreased expression of CRLF2 mRNA
CTD
PMID:22563483
NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642
G
Dgki
diacylglycerol kinase, iota
increases expression
ISO
pyridaben results in increased expression of DGKI mRNA
CTD
PMID:22563483
NCBI chr 4:65,410,878...65,872,733
Ensembl chr 4:65,420,108...65,872,733
G
Dip2b
disco-interacting protein 2 homolog B
increases expression
ISO
pyridaben results in increased expression of DIP2B mRNA
CTD
PMID:22563483
NCBI chr 7:131,174,575...131,350,417
Ensembl chr 7:131,174,567...131,349,092
G
Dmrta2
DMRT-like family A2
decreases expression
ISO
pyridaben results in decreased expression of DMRTA2 mRNA
CTD
PMID:22563483
NCBI chr 5:124,805,883...124,811,694
Ensembl chr 5:124,805,883...124,811,630
G
Drd4
dopamine receptor D4
decreases expression
ISO
pyridaben results in decreased expression of DRD4 mRNA
CTD
PMID:22563483
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
G
Egr4
early growth response 4
decreases expression
ISO
pyridaben results in decreased expression of EGR4 mRNA
CTD
PMID:22563483
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
G
Elane
elastase, neutrophil expressed
increases expression
ISO
pyridaben results in increased expression of ELANE mRNA
CTD
PMID:22563483
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Esr1
estrogen receptor 1
increases activity multiple interactions
ISO
pyridaben results in increased activity of ESR1 protein pyridaben binds to and results in increased activity of ESR1 protein; pyridaben inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
CTD
PMID:20143881 PMID:30818834 PMID:33049310
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
ISO
pyridaben inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
CTD
PMID:30818834
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esrra
estrogen related receptor, alpha
multiple interactions
ISO
pyridaben inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; pyridaben inhibits the reaction [XCT790 results in decreased activity of ESRRA protein]
CTD
PMID:30818834
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
Etl4
enhancer trap locus 4
increases expression
ISO
pyridaben results in increased expression of ETL4 mRNA
CTD
PMID:22563483
NCBI chr17:82,841,075...83,304,868
Ensembl chr17:82,495,041...83,304,715
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
pyridaben results in decreased expression of H2BC9 mRNA
CTD
PMID:22563483
NCBI chr17:42,470,593...42,478,590
G
H3c1
H3 clustered histone 1
decreases expression
ISO
pyridaben results in decreased expression of H3C1 mRNA
CTD
PMID:22563483
NCBI chr17:41,368,379...41,368,902
Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856
G
Hexb
hexosaminidase subunit beta
multiple interactions
EXP
zinc chloride inhibits the reaction [pyridaben results in increased secretion of HEXB protein]
CTD
PMID:15272608
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
G
Hmx3
H6 family homeobox 3
decreases expression
ISO
pyridaben results in decreased expression of HMX3 mRNA
CTD
PMID:22563483
NCBI chr 1:186,313,237...186,315,201
Ensembl chr 1:186,313,063...186,315,201
G
Hs3st6
heparan sulfate-glucosamine 3-sulfotransferase 6
decreases expression
ISO
pyridaben results in decreased expression of HS3ST6 mRNA
CTD
PMID:22563483
NCBI chr10:13,781,999...13,788,133
Ensembl chr10:13,781,993...13,788,133
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
decreases expression
ISO
pyridaben results in decreased expression of IDH3A mRNA
CTD
PMID:30818834
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
G
Il6
interleukin 6
increases expression
EXP
pyridaben results in increased expression of IL6 mRNA
CTD
PMID:37357870
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhba
inhibin subunit beta A
increases expression
ISO
pyridaben results in increased expression of INHBA mRNA
CTD
PMID:22563483
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Insl3
insulin-like 3
decreases expression
ISO
pyridaben results in decreased expression of INSL3 mRNA
CTD
PMID:22563483
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
G
Itgb8
integrin subunit beta 8
increases expression
ISO
pyridaben results in increased expression of ITGB8 mRNA
CTD
PMID:22563483
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
G
Kcna2
potassium voltage-gated channel subfamily A member 2
increases expression
ISO
pyridaben results in increased expression of KCNA2 mRNA
CTD
PMID:22563483
NCBI chr 2:194,704,555...194,718,387
Ensembl chr 2:194,704,639...194,718,400
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
increases expression
ISO
pyridaben results in increased expression of KCNMA1 mRNA
CTD
PMID:22563483
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kif1b
kinesin family member 1B
increases expression
ISO
pyridaben results in increased expression of KIF1B mRNA
CTD
PMID:22563483
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
G
Klf2
KLF transcription factor 2
decreases expression
ISO
pyridaben results in decreased expression of KLF2 mRNA
CTD
PMID:22563483
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klhl15
kelch-like family member 15
increases expression
ISO
pyridaben results in increased expression of KLHL15 mRNA
CTD
PMID:22563483
NCBI chr X:58,994,726...59,050,207
Ensembl chr X:58,995,461...59,046,069
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
pyridaben results in increased expression of LAMC2 mRNA
CTD
PMID:22563483
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
pyridaben results in increased expression of LIFR mRNA
CTD
PMID:22563483
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lrp4
LDL receptor related protein 4
increases expression
ISO
pyridaben results in increased expression of LRP4 mRNA
CTD
PMID:22563483
NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:77,429,798...77,483,593
G
Lrrc63
leucine rich repeat containing 63
decreases expression
ISO
pyridaben results in decreased expression of LRRC63 mRNA
CTD
PMID:22563483
NCBI chr15:50,400,199...50,437,321
Ensembl chr15:50,400,200...50,437,321
G
Ltb4r2
leukotriene B4 receptor 2
decreases expression
ISO
pyridaben results in decreased expression of LTB4R2 mRNA
CTD
PMID:22563483
NCBI chr15:29,258,712...29,260,531
Ensembl chr15:29,259,240...29,260,316
G
Ltf
lactotransferrin
increases expression
ISO
pyridaben results in increased expression of LTF mRNA
CTD
PMID:22563483
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Mapk15
mitogen-activated protein kinase 15
decreases expression
ISO
pyridaben results in decreased expression of MAPK15 mRNA
CTD
PMID:22563483
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
G
Marchf9
membrane associated ring-CH-type finger 9
decreases expression
ISO
pyridaben results in decreased expression of MARCHF9 mRNA
CTD
PMID:22563483
NCBI chr 7:62,879,017...62,882,495
Ensembl chr 7:62,879,018...62,882,495
G
Mboat2
membrane bound O-acyltransferase domain containing 2
increases expression
ISO
pyridaben results in increased expression of MBOAT2 mRNA
CTD
PMID:22563483
NCBI chr 6:41,471,135...41,597,599
Ensembl chr 6:41,471,161...41,593,485
G
Mdfi
MyoD family inhibitor
decreases expression
ISO
pyridaben results in decreased expression of MDFI mRNA
CTD
PMID:22563483
NCBI chr 9:13,156,806...13,175,218
Ensembl chr 9:13,156,866...13,175,217
G
Mpo
myeloperoxidase
increases expression
ISO
pyridaben results in increased expression of MPO mRNA
CTD
PMID:22563483
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mrtfb
myocardin related transcription factor B
increases expression
ISO
pyridaben results in increased expression of MRTFB mRNA
CTD
PMID:22563483
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
G
Muc6
mucin 6, oligomeric mucus/gel-forming
increases expression
ISO
pyridaben results in increased expression of MUC6 mRNA
CTD
PMID:22563483
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Myoc
myocilin
increases expression
ISO
pyridaben results in increased expression of MYOC mRNA
CTD
PMID:22563483
NCBI chr13:74,976,730...74,987,128
Ensembl chr13:74,976,730...74,987,127
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
pyridaben results in increased expression of NFAT5 mRNA
CTD
PMID:22563483
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases activity
ISO
pyridaben results in increased activity of NFE2L2 protein
CTD
PMID:30818834
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfib
nuclear factor I/B
increases expression
ISO
pyridaben results in increased expression of NFIB mRNA
CTD
PMID:22563483
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Nipbl
NIPBL, cohesin loading factor
increases expression
ISO
pyridaben results in increased expression of NIPBL mRNA
CTD
PMID:22563483
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to pyridaben
CTD
PMID:18463239
NCBI chr 8:98,892,168...99,003,912
Ensembl chr 8:98,873,398...99,020,645
G
Nps
neuropeptide S
increases expression
ISO
pyridaben results in increased expression of NPS mRNA
CTD
PMID:22563483
NCBI chr 1:190,077,040...190,080,821
Ensembl chr 1:190,077,040...190,080,821
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
pyridaben binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
decreases expression
ISO
pyridaben results in decreased expression of NR4A1 mRNA
CTD
PMID:22563483
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Odc1
ornithine decarboxylase 1
multiple interactions increases activity
ISO
pyridaben inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ODC1 mRNA] pyridaben results in increased activity of ODC1 protein
CTD
PMID:9834970
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Oxt
oxytocin/neurophysin I prepropeptide
decreases expression
ISO
pyridaben results in decreased expression of OXT mRNA
CTD
PMID:22563483
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Park7
Parkinsonism associated deglycase
decreases response to substance
ISO
PARK7 protein results in decreased susceptibility to pyridaben
CTD
PMID:21219333
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
pyridaben results in increased cleavage of PARP1 protein [pyridaben co-treated with Paraquat] results in increased cleavage of PARP1 protein
CTD
PMID:16237197
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pgr
progesterone receptor
multiple interactions
ISO
pyridaben inhibits the reaction [Promegestone results in increased activity of PGR protein]
CTD
PMID:30818834
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phox2a
paired-like homeobox 2a
decreases expression
ISO
pyridaben results in decreased expression of PHOX2A mRNA
CTD
PMID:22563483
NCBI chr 1:156,178,754...156,183,118
Ensembl chr 1:156,178,754...156,183,118
G
Plce1
phospholipase C, epsilon 1
increases expression
ISO
pyridaben results in increased expression of PLCE1 mRNA
CTD
PMID:22563483
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
pyridaben binds to and results in increased activity of PPARG protein; pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]
CTD
PMID:30818834 PMID:33049310
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression multiple interactions
ISO
pyridaben results in increased expression of PPARGC1A mRNA pyridaben inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]
CTD
PMID:22563483 PMID:30818834
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prr7
proline rich 7 (synaptic)
decreases expression
ISO
pyridaben results in decreased expression of PRR7 mRNA
CTD
PMID:22563483
NCBI chr17:9,164,375...9,173,669
Ensembl chr17:9,165,269...9,172,536
G
Retnlb
resistin like beta
increases expression
ISO
pyridaben results in increased expression of RETNLB mRNA
CTD
PMID:22563483
NCBI chr11:51,983,482...51,985,368
Ensembl chr11:51,983,483...51,985,368
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
increases expression
ISO
pyridaben results in increased expression of ROCK1 mRNA
CTD
PMID:22563483
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
G
S100a8
S100 calcium binding protein A8
increases expression
ISO
pyridaben results in increased expression of S100A8 mRNA
CTD
PMID:22563483
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
pyridaben results in increased expression of S100A9 mRNA
CTD
PMID:22563483
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Shox2
SHOX homeobox 2
decreases expression
ISO
pyridaben results in decreased expression of SHOX2 mRNA
CTD
PMID:22563483
NCBI chr 2:151,217,049...151,227,180
Ensembl chr 2:151,217,552...151,227,143
G
Slc8a1
solute carrier family 8 member A1
increases expression
ISO
pyridaben results in increased expression of SLC8A1 mRNA
CTD
PMID:22563483
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Smoc2
SPARC related modular calcium binding 2
increases expression
ISO
pyridaben results in increased expression of SMOC2 mRNA
CTD
PMID:22563483
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Snca
synuclein alpha
increases response to substance
ISO
SNCA protein results in increased susceptibility to pyridaben
CTD
PMID:16239214
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Socs1
suppressor of cytokine signaling 1
decreases expression
ISO
pyridaben results in decreased expression of SOCS1 mRNA
CTD
PMID:22563483
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Ston2
stonin 2
increases expression
ISO
pyridaben results in increased expression of STON2 mRNA
CTD
PMID:22563483
NCBI chr 6:110,567,485...110,676,376
Ensembl chr 6:110,567,485...110,676,376
G
Strbp
spermatid perinuclear RNA binding protein
increases expression
ISO
pyridaben results in increased expression of STRBP mRNA
CTD
PMID:22563483
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Tbck
TBC1 domain containing kinase
increases expression
ISO
pyridaben results in increased expression of TBCK mRNA
CTD
PMID:22563483
NCBI chr 2:221,175,749...221,348,058
Ensembl chr 2:221,175,785...221,348,126
G
Tcf15
transcription factor 15
decreases expression
ISO
pyridaben results in decreased expression of TCF15 mRNA
CTD
PMID:22563483
NCBI chr 3:140,638,984...140,644,766
Ensembl chr 3:140,638,984...140,644,766
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
pyridaben binds to and results in increased activity of THRA protein
CTD
PMID:33049310
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tmem42
transmembrane protein 42
decreases expression
ISO
pyridaben results in decreased expression of TMEM42 mRNA
CTD
PMID:22563483
NCBI chr 8:122,674,793...122,677,290
Ensembl chr 8:122,674,070...122,677,276
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
pyridaben results in increased expression of TNNT2 mRNA
CTD
PMID:22563483
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Trpm3
transient receptor potential cation channel, subfamily M, member 3
increases expression
ISO
pyridaben results in increased expression of TRPM3 mRNA
CTD
PMID:22563483
NCBI chr 1:219,673,200...220,557,610
Ensembl chr 1:219,672,892...220,560,717
G
Tusc1
tumor suppressor candidate 1
decreases expression
ISO
pyridaben results in decreased expression of TUSC1 mRNA
CTD
PMID:22563483
NCBI chr 5:108,089,952...108,091,315
Ensembl chr 5:108,090,613...108,091,224
G
Ubxn7
UBX domain protein 7
increases expression
ISO
pyridaben results in increased expression of UBXN7 mRNA
CTD
PMID:22563483
NCBI chr11:68,427,896...68,460,100
G
Ucn
urocortin
decreases expression
ISO
pyridaben results in decreased expression of UCN mRNA
CTD
PMID:22563483
NCBI chr 6:25,238,120...25,238,950
Ensembl chr 6:25,238,120...25,238,950
G
Unc13c
unc-13 homolog C
increases expression
ISO
pyridaben results in increased expression of UNC13C mRNA
CTD
PMID:22563483
NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223
G
Vdr
vitamin D receptor
increases activity
ISO
pyridaben results in increased activity of VDR protein
CTD
PMID:20143881
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Zbtb44
zinc finger and BTB domain containing 44
increases expression
ISO
pyridaben results in increased expression of ZBTB44 mRNA
CTD
PMID:22563483
NCBI chr 8:29,466,055...29,524,027
Ensembl chr 8:29,466,352...29,518,163
G
Zfp580
zinc finger protein 580
decreases expression
ISO
pyridaben results in decreased expression of ZFP580 mRNA
CTD
PMID:22563483
NCBI chr 1:68,787,118...68,789,286
Ensembl chr 1:68,787,118...68,789,286
G
Zhx3
zinc fingers and homeoboxes 3
increases expression
ISO
pyridaben results in increased expression of ZHX3 mRNA
CTD
PMID:22563483
NCBI chr 3:149,417,787...149,548,671
Ensembl chr 3:149,417,818...149,527,079
G
Esr1
estrogen receptor 1
increases activity
ISO
tetradifon results in increased activity of ESR1 protein
CTD
PMID:26139245
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases activity
ISO
tetradifon results in increased activity of ESR2 protein
CTD
PMID:26139245
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all